Kyle Malady is Director of DEXCOM INC. Currently has a direct ownership of 15,529 shares of DXCM, which is worth approximately $2.04 Million. The most recent transaction as insider was on May 18, 2023, when has been sold 2,885 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.5K
0% 3M change
0% 12M change
Total Value Held $2.04 Million

Kyle Malady Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2023
BUY
Grant, award, or other acquisition
-
2,885 Added 15.67%
15,529 Common Stock
May 20 2022
BUY
Grant, award, or other acquisition
-
979 Added 23.65%
3,161 Common Stock
May 21 2021
BUY
Grant, award, or other acquisition
-
910 Added 29.43%
2,182 Common Stock
Oct 11 2020
BUY
Grant, award, or other acquisition
-
1,272 Added 50.0%
1,272 Common Stock

Also insider at

VZ
VERIZON COMMUNICATIONS INC Communication Services
KM

Kyle Malady

Director
New York, NY

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Track Activities on DXCM